Although EPHB3 expression in CRCs has been reported by previous studies, to our knowledge, this is the most comprehensive study to demonstrate the alterations of EPHB3 expression throughout CRC development and progression. This evidence concerns the gene EPHB3 and colorectal carcinoma.